REFERENCES
1. CroFab®. Prescribing information. BTG
International Inc.; August 2018. 2. WHO Expert Committee on
Biological Standardization. WHO Technical Report Series, No. 1004, Annex 5;
2017. Accessed September 13, 2023.
https://cdn.who.int/media/docs/default-source/biologicals/blood-products/document-migration/antivenomglrevwho_trs_1004_web_annex_5.pdf?sfvrsn=ef4b2aa5_3&download=true
3. Laustsen AH, María Gutiérrez J, Knudsen C, et al.
Pros and cons of different therapeutic antibody formats for recombinant antivenom
development. Toxicon. 2018;146:151-175. 4. Gerardo CJ,
Quackenbush E, Lewis B, et al. The efficacy of Crotalidae polyvalent immune Fab
(ovine) antivenom versus placebo plus optional rescue therapy on recovery from
copperhead snake envenomation: a randomized, double-blind, placebo-controlled,
clinical trial. Ann Emerg Med. 2017;70(2):233-244.